From the National Institutes of Health and university spinoffs to Big Pharma and established biotechnology companies, our lawyers represent all types of human and veterinary pharmaceutical providers.

Our pharmaceutical clients rely on our lawyers for strategic intellectual property counsel as their products progress through regulatory approval, both in the United States and abroad.   No matter the type of drug, whether small molecule therapeutics or novel recombinant DNA and molecular biology-based products, we support them in every country, every step of the way.  Our lawyers also have significant experience helping clients protect their pharmaceutical products from infringement both in the United States and in nearly every country in the world.